Attention Biotech Investors: February PDUFA Catalysts Come Calling

By: via Benzinga
Although the action was light on the FDA approval front, biotech stocks took the spotlight in January, thanks to a few ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.